Expression of CD44s and CD44v6 in Lung Cancer and Their Correlation with Prognostic Factors

American Cancer Society. Cancer Facts & Figures 2010. Atlanta, GA: American Cancer Society, 2010.

Ogino S. , Nishida N. , Umemoto R. Two-state conformations in the hyaluronan-binding domain regulate CD44 adhesiveness under flow condition. Structure 2010; 12: 649–56.

Haynes B.F. , Liao H.X. , Patton K.L. The transmembrane hyaluronate receptor (CD44): multiple functions, multiple forms. Cancer Cells 1991; 3: 347–50.

Tölg C. , Hofmann M. , Herrlich P. , Ponta H. Splicing choice from ten variant exons establishes CD44 variability. Nucleic Acid Res 1993; 21: 1225–9.

Wang S.J. , Wong G. , de Heer A.M. , Xia W. , Bourguignon L.Y. CD44 variant isoforms in head and neck squamous cell carcinoma progression. Laryngoscope 2009; 119: 1518–30.

Yamada Y. , Itano N. , Narimatsu H. CD44 variant exon 6 expressions in colon cancer assessed by quantitative analysis using real time reverse transcriptase-polymerase chain reaction. Oncol Rep 2003; 10: 1919–24.

Afify A.M. , Craig S. , Paulino A.F. , Stern R. Expression of hyaluronic acid and its receptors, CD44s and CD44v6, in normal, hyperplastic, and neoplastic endometrium. Ann Diagn Pathol 2005; 9: 312–8.

Afify A.M. , Ferguson A.W. , Davila R.M. , Werness B.A. Expression of CD44S and CD44v5 is more common in stage III than in stage I serous ovarian carcinomas. Appl Immunohistochem Mol Morphol 2001; 9: 309–14.

Günthert U. , Hofmann M. , Rudy W. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991; 65: 13–24.

Kaufmann M. , Heider K.H. , Sinn H.P. , Von Minckwitz G. , Ponta H. , Herrlich P. CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet 1995; 345: 615–9.

Ghaffarzadehgan K. , Jafarzadeh M. , Raziee H.R. Expression of cell adhesion molecule CD44 in gastric adenocarcinoma and its prognostic importance. World J Gastroenterol 2008; 14: 6376–81.

Ngan C.Y. , Yamamoto H. , Seshimo I. A multivariate analysis of adhesion molecules expression in assessment of colorectal cancer. J Surg Oncol 2007; 95: 652–62.

Penno M.B. , August J.T. , Baylin S.B. Expression of CD44 in human lung tumors. Cancer Res 1994; 54: 1381–7.

Wimmel A. , Kogan E. , Ramaswamy A. , Schuermann M. Variant expression of CD44 in preneoplastic lesions of the lung. Cancer 2001; 92: 1231–6.

McKee C. , Penno M.B. , Cowman M. Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44. J Clin Invest 1996; 98: 2403–13.

Johnson P. , Ruffell B. CD44 and its role in inflammation and inflammatory diseases. Inflamm Allergy Drug Targets 2009; 3: 208–20.

Van der Windt G.J. , Florquin S. , De Vos A.F. CD44 deficiency is associated with increased bacterial clearance but enhanced lung inflammation during Gram-negative pneumonia. Am J Pathol 2010; 177: 2483–94.

Sconocchia G. , Campagnano L. , Adorno D. CD44 ligation on peripheral blood polymorphonuclear cells induces interleukin-6 production. Blood 2001; 97: 3621–27.

Svee K. , White J. , Vaillant P. Acute lung injury fibroblast migration and invasion of a fibrin matrix is mediated by CD44. J Clin Invest 1996; 98: 1713–27.

DeGrendele H.C. , Kosfiszer M. , Estess P. , Siegelman M.H. CD44 activation and associated primary adhesion is inducible via T cell receptor stimulation. J Immunol 1997; 159: 2546–53.

Clark R.A. , Alon R. , Springer T.A. CD44 and hyaluronan-dependent rolling interactions of lymphocytes on tonsillar stroma. J Cell Biol 1996; 134: 1075–87.

Puré E. , Cuff C.A. A crucial role for CD44 in inflammation. Trends Mol Med 2001; 7: 213–21.

DeGrendele H.C. , Estess P. , Siegelman M.H. Requirement for CD44 in activated T cell extravasation into an inflammatory site. Science 1997; 278: 672–5.

Schmits R. , Filmus J. , Gerwin N. CD44 regulates hematopoietic progenitor distribution, granuloma formation, and tumorigenicity. Blood 1997, 90: 2217–33.

Teder P. , Vandivier R.W. , Jiang D. Resolution of lung inflammation by CD44. Science 2002; 296: 155–8.

Sahu S. , Lynn W.S. Hyaluronic acid in the pulmonary secretions of patients with alveolar proteinosis. Inflammation 1978; 3: 149–58.

Hällgren R. , Samuelsson T. , Laurent T.C. , Modig J. Accumulation of hyaluronan (hyaluronic acid) in the lung in adult respiratory distress syndrome. Am Rev Respir Dis 1989; 139: 682–7.

Wimmel A. , Schilli M. , Kaiser U. Preferential histiotypic expression of CD44-isoforms in human lung cancer. Lung Cancer 1997; 16: 151–72.

Fukuse T. , Hirata T. , Naiki H. , Hitomi S. , Wada H. Expression of proliferating cell nuclear antigen and CD44 variant isoforms in the primary and metastatic sites of nonsmall cell lung carcinoma with intrapulmonary metastases. Cancer 1999; 86: 1174–81.

Kondo K. , Miyoshi T. , Hino N. High frequency expressions of CD44 standard and variant forms in non-small cell lung cancers, but not in small cell lung cancers. J Surg Oncol 1998; 69: 128–36.

Ariza A. , Mate J.L. , Isamat M. Standard and variant CD44 isoforms are commonly expressed in lung cancer of the non-small cell type but not of the small cell type. J Pathol 1995; 177: 363–8.

Munchar M.J. , Sharifah N.A. , Jamal R. , Looi L.M. CD44s expression correlated with the International Neuroblastoma Pathology Classification (Shimada system) for neuroblastic tumours. Pathology 2003; 35: 125–9.

Valentiner U. , Valentiner F.U. , Schumacher U. Expression of CD44 is associated with a metastatic pattern of human neuroblastoma cells in a SCID mouse xenograft model. Tumour Biol 2008; 29: 152–60.

Bourguignon L.Y. Hyaluronan-mediated CD44 activation of Rho-GTPase signaling and cytoskeleton function promotes tumor progression. Semin Cancer Biol 2008; 18: 251–9.

Bourguignon L. , Zhu H. , Shao L. , Chen Y. Ankyrin–Tiam1 interaction promotes Rac1 signaling and metastatic breast tumor cell invasion and migration. J Cell Biol 2000; 150: 177–91.

Tran T.A. , Kallakury B.V. , Sheehan C.E. , Ross J.S. Expression of CD44 standard form and variant isoforms in non-small cell lung carcinomas. Hum Pathol 1997; 28: 809–14.

Miyoshi T. , Kondo K. , Hino N. , Uyama T. , Monden Y. The expression of the CD44 variant exon 6 is associated with lymph node metastasis in non-small cell lung cancer. Clin Cancer Res 1997; 3: 1289–97.

Ramasami S. , Kerr K.M. , Chapman A.D. , King G. , Cockburn J.S. , Jeffrey R.R. Expression of CD44v6 but not E-cadherin or beta-catenin influences prognosis in primary pulmonary adenocarcinoma. J Pathol 2000; 192: 427–32.

Hirata T. , Fukuse T. , Naiki H. , Hitomi S. , Wada H. Expression of CD44 variant exon 6 in stage I non-small cell lung carcinoma as a prognostic factor. Cancer Res 1998; 58: 1108–10.

Givehchian M. , Woerner S.M. , Lacroix J. Expression of CD44 splice variants in normal respiratory epithelium and bronchial carcinomas: no evidence for altered CD44 splicing in metastasis. Oncogene 1996; 12: 1137–44.

Suzuki H. , Yamashiro K. Reduced expression of CD44 v3 and v6 is related to invasion in lung adenocarcinoma. Lung Cancer 2002; 38: 137–41.

Nguyen V.N. , Mirejovský T. , Melinová L. , Mandys V. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance. Neoplasma 2000; 47: 400–8.